TRV GP IV, LLC
- SEC CIK
- 0001688325
- Latest filing
- Aug 7, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 7, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 2
- 0 vs. Q1 2026
- Portfolio value
- $253.7M
- −$13.2M (−5.0%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MAZEMaze Therapeutics, Inc. | COM | 4,473,958 | $133.5M | 52.6% | 00.0% | Unchanged | History |
| TNGXTango Therapeutics, Inc. | COM | 6,374,574 | $120.2M | 47.4% | 00.0% | Unchanged | History |